PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

Detalles Bibliográficos
Autores principales: Hijiya, N., Kapoor, S., Hoch, M., Descamps, L., Bayar, M. A., Ramscar, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431387/
http://dx.doi.org/10.1097/01.HS9.0000850464.45271.b3
_version_ 1784780041677176832
author Hijiya, N.
Kapoor, S.
Hoch, M.
Descamps, L.
Bayar, M. A.
Ramscar, N.
author_facet Hijiya, N.
Kapoor, S.
Hoch, M.
Descamps, L.
Bayar, M. A.
Ramscar, N.
author_sort Hijiya, N.
collection PubMed
description
format Online
Article
Text
id pubmed-9431387
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94313872022-08-31 PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) Hijiya, N. Kapoor, S. Hoch, M. Descamps, L. Bayar, M. A. Ramscar, N. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431387/ http://dx.doi.org/10.1097/01.HS9.0000850464.45271.b3 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Hijiya, N.
Kapoor, S.
Hoch, M.
Descamps, L.
Bayar, M. A.
Ramscar, N.
PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
title PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
title_full PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
title_fullStr PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
title_full_unstemmed PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
title_short PB1903: TRIAL IN PROGRESS: A MULTICENTER, OPEN-LABEL, PHASE IB/II STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
title_sort pb1903: trial in progress: a multicenter, open-label, phase ib/ii study to determine the dose and safety of asciminib in pediatric patients with chronic myeloid leukemia in chronic phase (cml-cp)
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431387/
http://dx.doi.org/10.1097/01.HS9.0000850464.45271.b3
work_keys_str_mv AT hijiyan pb1903trialinprogressamulticenteropenlabelphaseibiistudytodeterminethedoseandsafetyofasciminibinpediatricpatientswithchronicmyeloidleukemiainchronicphasecmlcp
AT kapoors pb1903trialinprogressamulticenteropenlabelphaseibiistudytodeterminethedoseandsafetyofasciminibinpediatricpatientswithchronicmyeloidleukemiainchronicphasecmlcp
AT hochm pb1903trialinprogressamulticenteropenlabelphaseibiistudytodeterminethedoseandsafetyofasciminibinpediatricpatientswithchronicmyeloidleukemiainchronicphasecmlcp
AT descampsl pb1903trialinprogressamulticenteropenlabelphaseibiistudytodeterminethedoseandsafetyofasciminibinpediatricpatientswithchronicmyeloidleukemiainchronicphasecmlcp
AT bayarma pb1903trialinprogressamulticenteropenlabelphaseibiistudytodeterminethedoseandsafetyofasciminibinpediatricpatientswithchronicmyeloidleukemiainchronicphasecmlcp
AT ramscarn pb1903trialinprogressamulticenteropenlabelphaseibiistudytodeterminethedoseandsafetyofasciminibinpediatricpatientswithchronicmyeloidleukemiainchronicphasecmlcp

Ejemplares similares